Urinary Tract Infections After Urogynecologic Surgery: Risk Factors, Timeline, and Uropathogens.


Journal

Urogynecology (Philadelphia, Pa.)
ISSN: 2771-1897
Titre abrégé: Urogynecology (Phila)
Pays: United States
ID NLM: 9918452588006676

Informations de publication

Date de publication:
01 07 2023
Historique:
medline: 26 6 2023
pubmed: 27 1 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Urinary tract infection (UTI) is a common and potentially avoidable postoperative (PO) adverse event after urogynecologic surgery. Understanding pathophysiology will help prevent the associated morbidity of the disease and treatment of PO-UTI. The objective of this study is to determine the following: (1) risk factors for both PO-UTI and PO recurrent UTI (RUTI) after urogynecologic surgery, (2) temporal distribution of UTI, and (3) uropathogen identification. Women undergoing urogynecologic surgery were retrospectively reviewed. Urinary tract infection was defined by culture or antibiotic prescription for symptoms. Recurrent UTI was defined as occurring outside a 6-week perioperative period. The χ 2 test or Fischer exact and Student t tests or Mann-Whitney U test were used as appropriate. Individual odds ratio (OR), 95% confidence interval [CI], and sequential multivariable logistic regression were calculated. Statistical significance was set at P < 0.05. The 6-week PO-UTI rate after 33,626 procedures was 12.9%. Recurrent UTI increased from 3.7% preoperatively to 4.4% postoperatively ( P < 0.001). A 6-week preoperative UTI and RUTI increased the risk of 6-week PO-UTI (OR, 1.65; 95% CI < 1.26-2.16; P = 0.001 and OR, 2.19; 95% CI, 1.84-2.62; P < 0.001, respectively) and PO-RUTI (OR, 2.95; 95% CI, 2.11-4.11; P < 0.001 and OR, 6.79; 95% CI, 5.61-8.23; P < 0.001, respectively). Compared with pelvic organ prolapse (POP) surgery only, stress urinary incontinence (SUI) surgery (OR 1.57[1.30-1.89]), and combined POP/SUI surgery (OR, 1.36; 95% CI, 1.13-1.63]) increased the risk of PO-RUTI ( P < 0.001). Urinary tract infection within 1 week preoperatively was protective against 6-week PO-UTI (OR, 0.68; 95% CI, 0.48-0.97; P = 0.035). No perioperative factors were protective of PO-RUTI. The PO-RUTI rate in the first year after urogynecologic surgery is low; however, SUI procedures may increase PO-RUTI risk. Potentially, modifiable risk factors for both PO-UTI and PO-RUTI include UTI diagnosis within 6 weeks preoperatively or preoperative RUTI diagnosis. Retesting women the week before surgery to ensure adequate treatment of preoperative UTI may reduce 6-week PO-UTI.

Identifiants

pubmed: 36701315
doi: 10.1097/SPV.0000000000001317
pii: 02273501-990000000-00061
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

632-640

Informations de copyright

Copyright © 2022 American Urogynecologic Society. All rights reserved.

Déclaration de conflit d'intérêts

The authors have declared they have no conflicts of interest.

Références

Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med . 2010;362(22):2066–2076. doi:10.1056/NEJMoa0912658.
doi: 10.1056/NEJMoa0912658
Jackson D, Higgins E, Bracken J, et al. Antibiotic prophylaxis for urinary tract infection after midurethral sling. Female Pelvic Med Reconstr Surg . 2013;19(3):137–141. doi:10.1097/SPV.0b013e318285ba53.
doi: 10.1097/SPV.0b013e318285ba53
Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med . 2007;356(21):2143–2155. doi:10.1056/NEJMoa070416.
doi: 10.1056/NEJMoa070416
Wei JT, Nygaard I, Richter HE, et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med . 2012;366(25):2358–2367. doi:10.1056/NEJMoa1111967.
doi: 10.1056/NEJMoa1111967
Pokrzywa CJ, Papageorge CM, Kennedy GD. Preoperative urinary tract infection increases postoperative morbidity. J Surg Res . 2016;205(1):213–220. doi:10.1016/j.jss.2016.06.025.
doi: 10.1016/j.jss.2016.06.025
Mitchell BG, Ferguson JK, Anderson M, et al. Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hosp Infect . 2016;93(1):92–99. doi:10.1016/j.jhin.2016.01.012.
doi: 10.1016/j.jhin.2016.01.012
Rosenthal VD, Dwivedy A, Calderón ME, et al. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J Inf Secur . 2011;62(2):136–141. doi:10.1016/j.jinf.2010.12.004.
doi: 10.1016/j.jinf.2010.12.004
Swami SK, Liesinger JT, Shah N, et al. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc . 2012;87(8):753–759. doi:10.1016/j.mayocp.2012.02.025.
doi: 10.1016/j.mayocp.2012.02.025
Sutkin G, Alperin M, Meyn L, et al. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J . 2010;21(8):955–961. doi:10.1007/s00192-010-1137-x.
doi: 10.1007/s00192-010-1137-x
Nygaard I, Brubaker L, Chai TC, et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J . 2011;22(10):1255–1265. doi:10.1007/s00192-011-1429-9.
doi: 10.1007/s00192-011-1429-9
Fok CS, McKinley K, Mueller ER, et al. Day of surgery urine cultures identify urogynecologic patients at increased risk for postoperative urinary tract infection. J Urol . 2013;189(5):1721–1724. doi:10.1016/j.juro.2012.11.167.
doi: 10.1016/j.juro.2012.11.167
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J . 2010;21(5):5–26. doi:10.1007/s00192-016-3140-3.
doi: 10.1007/s00192-016-3140-3
Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis . 2005;40(5):643–654. doi:10.1086/427507.
doi: 10.1086/427507
Kow N, Holthaus E, Barber MD. Bacterial uropathogens and antibiotic susceptibility of positive urine cultures in women with pelvic organ prolapse and urinary incontinence. Neurourol Urodyn . 2016;35(1):69–73. doi:10.1002/nau.22680.
doi: 10.1002/nau.22680
Sopeña-Sutil R, Medina-Polo J, Justo-Quintas J, et al. Healthcare-associated infections after lower urinary tract endoscopic surgery: analysis of risk factors, associated microorganisms and patterns of antibiotic resistance. Urol Int . 2018;100(4):440–444. doi:10.1159/000488251.
doi: 10.1159/000488251
Foxman B. Urinary tract infection syndromes. Infect Dis Clin N Am . 2014;28(1):1–13. doi:10.1016/j.idc.2013.09.003.
doi: 10.1016/j.idc.2013.09.003
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med . 1993;329(11):753–756. doi:10.1056/NEJM199309093291102.
doi: 10.1056/NEJM199309093291102
Ferrante KL, Wasenda EJ, Jung CE, et al. Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: a randomized clinical trial. Female Pelvic Med Reconstr Surg . 2019:27;112–117. doi:10.1097/SPV.0000000000000749.
doi: 10.1097/SPV.0000000000000749
Thomas-White KJ, Hilt EE, Fok C, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J . 2016;27(5):723–733. doi:10.1007/s00192-015-2847-x.
doi: 10.1007/s00192-015-2847-x
Karstens L, Asquith M, Davin S, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol . 2016;6:78. doi:10.3389/fcimb.2016.00078.
doi: 10.3389/fcimb.2016.00078
Hammett J, Lukman R, Oakes M, et al. Recurrent urinary tract infection after midurethral sling. Female Pelvic Med Reconstr Surg . 2016;22(6):438–441. doi:10.1097/SPV.0000000000000308.
doi: 10.1097/SPV.0000000000000308
Gehrich AP, Patzwald JR, Kern ME, et al. The incidence of early and recurrent urinary tract infections after midurethral sling operations. Mil Med . 2014;179(11):1301–1306. doi:10.7205/MILMED-D-14-00122.
doi: 10.7205/MILMED-D-14-00122
Stamm WE, Counts GW, Running KR, et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med . 1982;307(8):463–468. doi:10.1056/NEJM198208193070802.
doi: 10.1056/NEJM198208193070802

Auteurs

Lie H Chen (LH)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.

Linda T Brubaker (LT)

Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla.

Shawn A Menefee (SA)

From the Division of Urogynecology, Department of Obstetrics and Gynecology, Kaiser Permanente, Southern California, San Diego.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH